FOLH1 and prostate cancer: As a type-2 transmembrane protein overexpressed on the surface of prostate and prostate cancer cells, the prostate-specific membrane antigen (PSMA) has emerged as a promising imaging target for men afflicted with prostate cancer (PC) [1, 2].